The global chicken pox market is experiencing significant growth driven by the widespread prevalence of the varicella-zoster virus, low vaccination r ...

Investing.com -- Sanofi (EPA: SASY) shares fell more than 2% on Thursday after the pharmaceutical and healthcare company ...

Drugmaker Sanofi said on Thursday it believes the impact from U.S. tariffs to be manageable as it raised its sales growth ...

Sanofi UK General Manager Ahmed Moussa reflects on the current landscape of type 1 diabetes in the UK and explores what must ...

Net profit more than tripled to 3.94 billion euros, flattered by a gain from Sanofi's sale of a majority stake in its Opella consumer-healthcare arm. Business EPS came in at 1.59 euros, up 8.3% ...

In 2025, sales are anticipated to grow by a high single-digit percentage at CER (previously mid-to-high single-digit). Sanofi confirms the expectation of a strong business EPS rebound with growth at a ...

France's Sanofi said on Thursday that it expects annual sales to grow by high single-digit percentage, helped by strong ...

A healthcare-focused panel discussion at this year’s Sapics Conference in Cape Town spotlighted Africa’s emergence as a ...

Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma Designation granted for IgG1-based GPRC5D monoclonal antibody for the potential treatment ...

Paris: Sanofi has received orphan drug designation from the US Food and Drug Administration (FDA) for SAR446523, an ...

Sanofi's SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma <li /> Designation grante ...

Against steep odds and well-established paradigms, these four companies have successfully been commercializing their products ...